ACTINOMYCOTIC PULMONARY INFECTION

ACTINOMYCOTIC PULMONARY INFECTION was reported 83 times

ACTINOMYCOTIC PULMONARY INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
1 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
2 Pyridone [EPC] 4 0.0001
3 Sulfone [EPC] 1 0.0001
4 HER2/neu Receptor Antagonist [EPC] 5 0.0001
5 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
6 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
7 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
8 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
9 Antimycobacterial [EPC] 1 0.0000
10 Antirheumatic Agent [EPC] 4 0.0000
11 Alkaloid [EPC] 1 0.0000
12 Anti-IgE [EPC] 3 0.0000
13 Platinum-based Drug [EPC] 9 0.0000
14 Aminosalicylate [EPC] 3 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 13 0.0000
16 Topoisomerase Inhibitor [EPC] 2 0.0000
17 Corticosteroid [EPC] 23 0.0000
18 Proteasome Inhibitor [EPC] 2 0.0000
19 Methylxanthine [EPC] 1 0.0000
20 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
21 Tetracycline-class Drug [EPC] 1 0.0000
22 Azole Antifungal [EPC] 2 0.0000
23 Nucleoside Analog Antiviral [EPC] 1 0.0000
24 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
25 Purine Antimetabolite [EPC] 1 0.0000
26 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
27 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
28 Fluoroquinolone Antibacterial [EPC] 1 0.0000
29 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
30 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
31 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
32 Janus Kinase Inhibitor [EPC] 1 0.0000
33 Microtubule Inhibitor [EPC] 1 0.0000
34 Thalidomide Analog [EPC] 3 0.0000
35 Kinase Inhibitor [EPC] 3 0.0000
36 Loop Diuretic [EPC] 2 0.0000
37 Alkylating Drug [EPC] 1 0.0000
38 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000